Skip to content
RNAWiki
Checking…
All public datasets

Public dataset

Recorded source agreement and disagreement

Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.

What this does not mean: agree can mean only that sources print the same normalized reading; it is not clinical-context equivalence, independent replication, or proof. differ requires matching structured context and disjoint comparable values. not_comparable and insufficient_context are not disagreement.
Public rows
1,681
Generated
Schema version
source-consensus/2

Coverage

What this run contains

Compared medicine fields
1,681
Agree
1,282
Differ
0
Not comparable
12
Insufficient context
387
Fields represented
5
bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution

Method

How the rows were made

  1. Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
  2. One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
  3. Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
  4. not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
  5. The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
  6. Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
  7. documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.

Limits

Read these before using a row

  • Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
  • The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
  • Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
  • Only the recorded fields and source documents in this snapshot are compared.
  • A source count is the number of retained source records in the row, not a count of independent experiments.

Provenance

Source examples

abacavir · bioavailability · agree

15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)
The geometric mean absolute bioavailability of the tablet was 83%.

alemtuzumab · volumeOfDistribution · not_comparable

2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)
Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).

abiraterone · halfLife · insufficient_context

31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)
Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.

Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.

Schema

Fields in the public projection

FieldTypeMeaning
medicineSlugstringStable RNAWiki medicine route key.
fieldstringRecorded pharmacokinetic field being compared.
comparisonStatestringagree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero.
comparisonReasonsstring[]Deterministic codes explaining the state.
documentsExaminednumberRecorded source documents considered for the field.
sourceCountnumberRecorded source readings represented.
agreementRatenumberShare represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability.
readingsconsensus-reading[]Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt.

Reader

Search and filter the rows

Case-insensitive text search over the public fields named for this dataset.

Exact comparability state.

Exact recorded field key.

Clear

Showing 1,011–1,020 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.

  1. Projected row 1011

    Medicine slug
    milnacipran
    Compared field
    proteinBinding
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    5
    Source count
    5
    Agreement rate
    1
    Recorded readings

    1. 13%

      Numeric value
      13
      Unit
      %
      Source records
      5

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 5 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8b720a1e-034b-4583-b80d-105a794cce74 (opens source in a new tab)

        Milnacipran label

        Version not recorded · Effective date not recorded

        Plasma protein binding is 13%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b66b1850-0d2a-41d6-b0ad-c676166394c7 (opens source in a new tab)

        Milnacipran label

        Version not recorded · Effective date not recorded

        Plasma protein binding is 13%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e39b4890-99e4-4e48-9f45-978d5ac9f402 (opens source in a new tab)

        Milnacipran label

        Version not recorded · Effective date not recorded

        Plasma protein binding is 13%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:16a4a314-f97e-4e91-95e9-576a3773d284 (opens source in a new tab)

        Milnacipran label

        Version not recorded · Effective date not recorded

        Plasma protein binding is 13%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:99efa59a-8458-4e04-8cb1-20abfc179228 (opens source in a new tab)

        Milnacipran label

        Version not recorded · Effective date not recorded

        Plasma protein binding is 13%.

  2. Projected row 1012

    Medicine slug
    minocycline
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    72
    Source count
    42
    Agreement rate
    0.857143
    Recorded readings

    1. 11.1 to 22.1 hours

      Numeric value
      11.1
      Unit
      hours
      Source records
      36

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 36 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55df55fb-18ec-4e00-9ed0-10bba0da513b (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b2a7493-2e6c-4901-b697-17eb188cc8dd (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:caa99901-467c-4e99-b7e9-fbabdf5d118c (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c7d0226e-5ac5-4fb1-9849-9d6663a2e8ad (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d5fcba91-6aa6-4072-aea5-fb8da65d9aac (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6224eeb-25be-4f1d-889f-809aaf338c8c (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:25acb785-6838-4e62-9e86-ddc30b2b759a (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:94d941e3-d3d8-4414-bd5c-4a92848e738f (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e6b04358-0f4c-4b21-a7f3-320d1e7bc0b8 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        CLINICAL PHARMACOLOGY Following a single dose of two minocycline hydrochloride 100 mg capsules administered to 18 normal fasting adult volunteers, maximum serum concentrations were attained in 1 to 4 hours (average 2.1 hours) and ranged from 2.1 to 5.1 mcg/mL (average 3.5 mcg/mL).The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f901a1ba-1716-8795-e053-6294a90a4e77 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1c363cbb-099b-7c73-e063-6394a90ae13f (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7e2390b7-242c-43ff-afb3-b0a5e79351d3 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ec93ad27-aff5-cbc7-e053-2a95a90adc7e (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a84c29a9-21a8-4965-b5a5-37b28e4af5a0 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d00d9bc4-c764-4ec1-beb0-44668637bcfb (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c96b1c5d-7004-4ee2-ad48-0ba963389f86 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f33fcfd2-b9ef-8e67-e053-2a95a90a0306 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0760232b-21a6-2b13-e063-6394a90a22c1 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ec20539-0421-4eac-95ed-e9acc6329fd0 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:093ff3c7-3ecc-47b4-9ae6-5218bcd262b2 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fd86ff45-37d0-4501-b9fb-e1836e4a8be4 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1229c84c-5627-4992-bb8a-7874b215c543 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0becbde8-6ec5-4830-a0d9-cfdb7b15eb84 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:65767ae3-b1ed-4492-90f2-703b2c7e0f38 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a5fc4d50-50b2-46e0-b722-4c6b2ec47d06 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:49e65b60-ffc9-4ccd-9aec-29a462358d27 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:12559b29-6568-4b99-a16e-6a87038981f7 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6597bdc9-9e3a-4c11-8b39-27b47f863287 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:87a137c6-dd53-44d3-ab49-ef78ebed35c8 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9013ca48-15f2-43cd-a51d-91cf65c72a7c (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:abaacdeb-2433-261a-e053-2995a90ae34e (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4f904969-5af3-461e-b557-d03a1e5c7292 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6f154720-706e-4177-8167-1bc893303f1b (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb3b9a7e-6724-4c2a-b3cb-236f522b31a8 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:192327c5-d2bc-1bd1-e063-6394a90a110b (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d67e4b17-7d44-4d72-9150-420d98cc6db3 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).

    2. 11.38 to 24.31 hours

      Numeric value
      11.38
      Unit
      hours
      Source records
      5

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 5 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bae17358-1180-4ca8-b163-f9a6f4f83a3d (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.38 to 24.31 hours (average 17.03 hours).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:799a9871-3249-471e-b88d-5d8f7d4b96ad (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.38 to 24.31 hours (average 17.03 hours).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43fbe7ff-4b67-474d-bf27-e5710d8d10ac (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.38 to 24.31 hours (average 17.03 hours).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d6e136ba-c9b1-4846-ae2a-98a29cb4504d (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.38 to 24.31 hours (average 17.03 hours).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3539f84e-b489-4914-96c1-ac3731032971 (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum half-life in the normal volunteers ranged from 11.38 to 24.31 hours (average 17.03 hours).

    3. 11 to 16 hours

      Numeric value
      11
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e415c323-8219-464b-9e3e-72c5a796cdaa (opens source in a new tab)

        Minocycline label

        Version not recorded · Effective date not recorded

        The serum elimination half-life of minocycline ranged from 11 to 16 hours in subjects with hepatic impairment (n=7) and 18 to 69 hours in subjects with renal impairment (n=5).

  3. Projected row 1013

    Medicine slug
    minoxidil
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    216
    Source count
    26
    Agreement rate
    1
    Recorded readings

    1. 4.2 hours

      Numeric value
      4.2
      Unit
      hours
      Source records
      26

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 26 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0b4fc036-9497-442b-b629-c4b386932789 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8f3800f0-b6da-4dfe-8c32-39bb5eb0262a (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:934508f8-9252-4d48-ae91-0ce96454dc7b (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:75b2832c-0a6c-4125-9514-19a6d8dbf6cf (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0dada91c-fa1c-4da4-ac0d-e68b017c8604 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b18e42ee-e5fa-441f-a6b6-1eb17836d668 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0354a7f5-5917-44dc-9963-411104008cb5 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8ccd07ab-07ed-4b42-b182-3d22b98abca7 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f00f3370-0313-4ce0-be7d-80db4477d9ae (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5fea137a-bc88-4b24-85db-538c90ad1870 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e39469e6-d4f6-450f-872c-6f538e67c71a (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:637718aa-a453-4acd-a992-590d637b63a3 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:40da3ec5-39db-42f1-b0d6-39d852130307 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7aa8d272-0e44-43df-9263-9d84b2aa8946 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ab30461c-f8c8-409d-9e24-d58ed8a34873 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6c85c69e-b5af-4e98-aacf-f65ad15d00d7 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b138c404-028c-4a73-a127-c96f2072e1f8 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cdfd3330-4836-4655-80a2-441380529a67 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:665cba3d-5f26-468a-a047-188a413fbede (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f0dae476-8d0b-4d0c-a505-ad51bf27a1c8 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6277d0dc-ac63-4393-a8ef-5350d9808876 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:02d7399f-94cc-f718-f214-587301edd138 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f76f6a05-11f8-48a6-98a3-b1407c228089 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d134237-3e94-258e-e063-6294a90af556 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a0066eac-cb58-49ef-a480-105cb1043c2b (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2e5a2976-06fb-43f9-e063-6294a90a3bf5 (opens source in a new tab)

        Minoxidil label

        Version not recorded · Effective date not recorded

        The average plasma half-life in man is 4.2 hours.

  4. Projected row 1014

    Medicine slug
    mirabegron
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    14
    Source count
    13
    Agreement rate
    1
    Recorded readings

    1. 29%

      Numeric value
      29
      Unit
      %
      Source records
      13

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 13 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e597023d-6dcc-4d9e-8ce0-2d28a5d862f3 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1a7337a4-2901-4e65-b666-7623fadb78f2 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2965e083-b678-43b9-8e13-2efddc0daad0 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2e40eb74-3b2a-47f7-bf31-fe27484f9bd2 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0054db9-e38a-4786-be2c-996fa5b8f47d (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba9e9e15-e666-4c56-9271-2e24739cfa2d (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f7a1758-8691-4e53-96d6-a01626ee8140 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bd73250-2b31-4b22-983b-15119846e697 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00826723-d25e-498a-b8d4-d17e5c14dda5 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:461b2b94-205a-4860-9cb4-d30267ada9df (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d22d3d12-8466-46db-bc19-d13e87c6115c (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b71b939e-8cb1-492c-8311-28f75dc4c682 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:98247602-29b9-4621-8eeb-519e40b883b9 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The absolute bioavailability increased from 29% at a dose of 25 mg to 35% at a dose of 50 mg.

  5. Projected row 1015

    Medicine slug
    mirabegron
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    14
    Source count
    14
    Agreement rate
    0.928571
    Recorded readings

    1. 50 hours

      Numeric value
      50
      Unit
      hours
      Source records
      13

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 13 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e597023d-6dcc-4d9e-8ce0-2d28a5d862f3 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Monotherapy for Adult OAB The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1a7337a4-2901-4e65-b666-7623fadb78f2 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Extended-Release Tablets Monotherapy for Adult OAB: The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2965e083-b678-43b9-8e13-2efddc0daad0 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Extended-Release Tablets Monotherapy for Adult OAB: The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2e40eb74-3b2a-47f7-bf31-fe27484f9bd2 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Monotherapy for Adult OAB The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0054db9-e38a-4786-be2c-996fa5b8f47d (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Extended-Release Tablets Monotherapy for Adult OAB: The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba9e9e15-e666-4c56-9271-2e24739cfa2d (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination MYRBETRIQ Monotherapy for Adult OAB The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f7a1758-8691-4e53-96d6-a01626ee8140 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Monotherapy for Adult OAB The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bd73250-2b31-4b22-983b-15119846e697 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Extended-Release Tablets Monotherapy for Adult OAB: The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00826723-d25e-498a-b8d4-d17e5c14dda5 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Extended-Release Tablets Monotherapy for Adult OAB: The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:461b2b94-205a-4860-9cb4-d30267ada9df (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Monotherapy for Adult OAB The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d22d3d12-8466-46db-bc19-d13e87c6115c (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Extended-Release Tablets Monotherapy for Adult OAB: The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b71b939e-8cb1-492c-8311-28f75dc4c682 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Monotherapy for Adult OAB The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:98247602-29b9-4621-8eeb-519e40b883b9 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron Extended-Release Tablets Monotherapy for Adult OAB The terminal elimination half-life (t 1/2 ) of mirabegron is approximately 50 hours in patients.

    2. 26 to 31 hours

      Numeric value
      26
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1c9022af-4841-4f3f-9737-1c5eef58e86b (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Elimination Mirabegron for Pediatric Neurogenic Detrusor Overactivity (NDO) The mean terminal elimination half-life (t 1/2 ) of mirabegron is approximately 26 to 31 hours in pediatric patients.

  6. Projected row 1016

    Medicine slug
    mirabegron
    Compared field
    tMax
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    14
    Source count
    3
    Agreement rate
    1
    Recorded readings

    1. 3 to 4 hours

      Numeric value
      3
      Unit
      hours
      Source records
      3

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 3 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e597023d-6dcc-4d9e-8ce0-2d28a5d862f3 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Population pharmacokinetic analysis predicted that the median T max of mirabegron at steady-state was 3 to 4 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1c9022af-4841-4f3f-9737-1c5eef58e86b (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Population pharmacokinetic analysis predicted that the median T max of mirabegron for extended-release oral suspension at steady-state was 3-4 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:98247602-29b9-4621-8eeb-519e40b883b9 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        Population pharmacokinetic analysis predicted that the median T max of mirabegron extended-release tablets at steady-state was 3- 4 hours.

  7. Projected row 1017

    Medicine slug
    mirabegron
    Compared field
    volumeOfDistribution
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    14
    Source count
    13
    Agreement rate
    0.615385
    Recorded readings

    1. 1670 L

      Numeric value
      1,670
      Unit
      L
      Source records
      8

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 8 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1a7337a4-2901-4e65-b666-7623fadb78f2 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1670 L following intravenous administration.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2965e083-b678-43b9-8e13-2efddc0daad0 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1670 L following intravenous administration.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0054db9-e38a-4786-be2c-996fa5b8f47d (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1670 L following intravenous administration.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba9e9e15-e666-4c56-9271-2e24739cfa2d (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1670 L following intravenous administration.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bd73250-2b31-4b22-983b-15119846e697 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1670 L following intravenous administration.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00826723-d25e-498a-b8d4-d17e5c14dda5 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1670 L following intravenous administration.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d22d3d12-8466-46db-bc19-d13e87c6115c (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1670 L following intravenous administration.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:98247602-29b9-4621-8eeb-519e40b883b9 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1670 L following intravenous administration.

    2. 1,670 L

      Numeric value
      1,670
      Unit
      L
      Source records
      5

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 5 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e597023d-6dcc-4d9e-8ce0-2d28a5d862f3 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1,670 L following intravenous administration.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2e40eb74-3b2a-47f7-bf31-fe27484f9bd2 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1,670 L following intravenous administration.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f7a1758-8691-4e53-96d6-a01626ee8140 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1,670 L following intravenous administration.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:461b2b94-205a-4860-9cb4-d30267ada9df (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1,670 L following intravenous administration.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b71b939e-8cb1-492c-8311-28f75dc4c682 (opens source in a new tab)

        Mirabegron label

        Version not recorded · Effective date not recorded

        The volume of distribution at steady-state (V ss ) is approximately 1,670 L following intravenous administration.

  8. Projected row 1018

    Medicine slug
    mirtazapine
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    92
    Source count
    92
    Agreement rate
    1
    Recorded readings

    1. 50%

      Numeric value
      50
      Unit
      %
      Source records
      92

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 92 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7a5545a0-4dbb-48ac-b0d2-477a8dd4b87e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81d9e47e-ae81-4755-a5ee-546a038fadb4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6837b69b-2f86-42cf-b48d-b4a3c7b5413f (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:40c95daa-bbd5-48d9-97e4-c87f2c1f0fa5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f19ab40-1a30-4ac2-9bd7-c2f8199e29e1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9f0f52e8-3318-4da2-b0d9-ea3d33bfe41e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1e0006b6-9405-95a7-e063-6294a90aa277 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed491abe-9412-428b-8e24-57242862c99a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df06ea51-a962-49d0-a449-137e2220ce7e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1fb26f9b-b075-471d-8cc3-fa39246ec2e4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5539fe37-546b-40a8-e063-6394a90ace1b (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b6b31703-e77d-4d1a-b1ac-da972117e356 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58bea4d8-084f-4c30-e063-6394a90a35cb (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9135e7db-cba4-4150-a69c-fdf2a347a785 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a0689ae-5650-42d1-ac9d-56dd2b467727 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b6e946c-54b5-40e3-918f-9cc29f04cd9a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8b2a08f7-4803-42fa-a2b5-5ea51f8ef7e4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e5478a6a-a29a-9f61-e053-2995a90a11d0 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1cc1a159-11ec-4040-817b-d57fa827a773 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7727fe84-f6cc-4b31-bc00-1ecf741ad361 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50718832-88fb-dec1-e063-6294a90ae468 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb134141-6069-4b86-abac-7783bf5df60d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:89ae6a33-933f-47aa-a2de-2a71cd3f7d44 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:598e441a-aa1a-6fb3-e063-6394a90a14aa (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67e753ad-9919-416b-9e8f-aab0fa808066 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3b7a5f44-8da6-4196-bb5d-8d2770af1b3a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ba111d1-cf92-4cd9-afcb-3bebd1bacd46 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20eafce1-50cd-0d9c-e063-6394a90ad6fe (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3699b988-6d9a-dcc1-e063-6394a90ab38d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:73b7bbd9-7dba-4559-890f-3f8dd821e215 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a80463be-f2d2-4074-9bd8-5e52b0832b3a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a4c012f0-50b6-42fb-9f06-a14632f23f2e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ded5b83b-f11a-4a6a-bf77-c5fe6dc4c4f5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bda4994-cdf5-47b4-aebc-7297347334e9 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Mirtazapine has an absolute bioavailability of about 50%.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:faba9bfd-6725-4917-ab48-24e58b397eb4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e839bb2-2f67-f224-e053-2a95a90ae5d8 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Mirtazapine has an absolute bioavailability of about 50%.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac976282-fb68-4db0-912a-28f075b0716c (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Mirtazapine has an absolute bioavailability of about 50%.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bb242b0-42ed-471a-b3c4-5ded1e292e80 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9675333e-3064-c8cb-a4b4-6c74d9a82f17 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:beaa0678-e4b9-4241-8b08-e69e2e49530f (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:356eb045-6347-49cc-818e-65b1cdff8f4e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55c5905c-6cb8-4ed4-8e69-97f733ca91b5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:98ad1917-a094-44f5-a28f-a64a8cfcd887 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3eed8213-a240-fc4b-e063-6294a90a3b05 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3b516a33-b164-4e4f-bc18-e9d1e591323a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Mirtazapine has an absolute bioavailability of about 50%.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a96e0d95-1a7b-4588-923a-2169b5506203 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Mirtazapine has an absolute bioavailability of about 50%.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ecf7826c-c583-4836-9b00-bf9e4b51a144 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20a724c6-feba-40e7-a35a-8a37de2e0136 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Mirtazapine has an absolute bioavailability of about 50%.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50ccc34a-4b89-4b07-b153-6c71c6924db1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a2f01ffd-fd48-499b-9126-8eb9048a5722 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Mirtazapine has an absolute bioavailability of about 50%.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8c03eb2b-6aed-40a1-a424-67ac1ab6085d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:35922615-7619-3852-e063-6394a90a2e55 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5127517f-b8d0-4af1-8a2f-5225719600bc (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58e9b4c6-531f-49c4-a640-6953e70892fe (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c2b38cc5-7738-44fa-9bef-89a18a1039b2 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d1b59d87-8442-4c15-8bb9-e39b198d8677 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:82a615a0-e74a-49cb-9a57-ffbb3df604d5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac3716fd-6971-4a70-ae7b-9f5117f3d880 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8c383c1-d1b3-ceaa-e053-6294a90a6053 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6ad0e695-92ee-4900-b194-a2455473370b (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Mirtazapine has an absolute bioavailability of about 50%.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:500dbfbe-2a00-496d-9e44-6e59d2c68ea2 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0cda063-00c5-0921-ee39-d4de1381f91a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bd532a25-cfde-4c7d-8015-ba40609fb95c (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:51269807-2b5a-e7aa-e063-6394a90ab657 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6d2ff278-0c80-4373-b77d-b5f186c4b991 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:93c4ddcf-ca4f-4a46-a7b7-1395fb0885d2 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aa05d606-29fd-443e-802b-1d65584d6bb1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f86f1175-806f-4416-af86-b1e28def8244 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dea8c09a-b759-1da7-e053-2a95a90a3346 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44779383-3ddb-41df-8766-da5d7bef385e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53311d08-9dfa-7bb1-e063-6394a90a6656 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:538679a1-d474-8e1c-e063-6394a90a15d7 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:10ea9d83-19c3-4f3b-a1cc-cfc48b42507f (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:222dfdde-6979-4b18-a7eb-ff1ad0a437c1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:552e2261-53db-4a27-b277-f7b62c3ea2ed (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:979eec8b-1bf4-466b-812e-85a111ce1cb5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f23631be-c7ae-46e9-b771-a70be17bc9f0 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:711aa80b-8fc6-49e6-9494-3db31d9b53a4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c47428e5-4717-4471-9231-ec8b5438205a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a8a4490-9243-4201-944d-cea27d3d69f5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b13d7ec-ecdc-482c-8fe2-b999bab3bbeb (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f54718d1-3ef7-4472-9e97-90e5fd30db4d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b4b9b66e-87a1-4dbb-9eaf-71221bcb2265 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aae4c58a-5cbd-45ef-b0f9-32bf28204f15 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6a5949f-5ebf-f37d-e053-2995a90adae5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e6e5cbf7-a958-4ef8-abcc-a7491edb9520 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Mirtazapine has an absolute bioavailability of about 50%.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:412abf0e-1f96-4d4d-bb56-a23d4699b14c (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e708e8bb-9b13-44d9-96f5-fd73a893a987 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:70439462-b632-4d21-8067-560162db3137 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c22c4325-4f1a-4d12-8039-d3b1263fa3ad (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:577c3ceb-316b-4c93-9b0c-0a4b1b4773e9 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e38c96d4-ea33-3f1a-e053-2a95a90a0903 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Absorption Mirtazapine has an absolute bioavailability of about 50% following oral administration.

  9. Projected row 1019

    Medicine slug
    mirtazapine
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    92
    Source count
    92
    Agreement rate
    1
    Recorded readings

    1. 20 to 40 hours

      Numeric value
      20
      Unit
      hours
      Source records
      92

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 92 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7a5545a0-4dbb-48ac-b0d2-477a8dd4b87e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81d9e47e-ae81-4755-a5ee-546a038fadb4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6837b69b-2f86-42cf-b48d-b4a3c7b5413f (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:40c95daa-bbd5-48d9-97e4-c87f2c1f0fa5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets Metabolism Mirtazapine is extensively metabolized after oral administration.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f19ab40-1a30-4ac2-9bd7-c2f8199e29e1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9f0f52e8-3318-4da2-b0d9-ea3d33bfe41e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1e0006b6-9405-95a7-e063-6294a90aa277 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed491abe-9412-428b-8e24-57242862c99a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine orally disintegrating tablets.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df06ea51-a962-49d0-a449-137e2220ce7e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets Metabolism Mirtazapine is extensively metabolized after oral administration.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1fb26f9b-b075-471d-8cc3-fa39246ec2e4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5539fe37-546b-40a8-e063-6394a90ace1b (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b6b31703-e77d-4d1a-b1ac-da972117e356 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58bea4d8-084f-4c30-e063-6394a90a35cb (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9135e7db-cba4-4150-a69c-fdf2a347a785 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a0689ae-5650-42d1-ac9d-56dd2b467727 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b6e946c-54b5-40e3-918f-9cc29f04cd9a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8b2a08f7-4803-42fa-a2b5-5ea51f8ef7e4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e5478a6a-a29a-9f61-e053-2995a90a11d0 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1cc1a159-11ec-4040-817b-d57fa827a773 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7727fe84-f6cc-4b31-bc00-1ecf741ad361 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50718832-88fb-dec1-e063-6294a90ae468 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb134141-6069-4b86-abac-7783bf5df60d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:89ae6a33-933f-47aa-a2de-2a71cd3f7d44 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:598e441a-aa1a-6fb3-e063-6394a90a14aa (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67e753ad-9919-416b-9e8f-aab0fa808066 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3b7a5f44-8da6-4196-bb5d-8d2770af1b3a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ba111d1-cf92-4cd9-afcb-3bebd1bacd46 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20eafce1-50cd-0d9c-e063-6394a90ad6fe (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3699b988-6d9a-dcc1-e063-6394a90ab38d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:73b7bbd9-7dba-4559-890f-3f8dd821e215 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine orally disintegrating tablets.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a80463be-f2d2-4074-9bd8-5e52b0832b3a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets Metabolism Mirtazapine is extensively metabolized after oral administration.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a4c012f0-50b6-42fb-9f06-a14632f23f2e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ded5b83b-f11a-4a6a-bf77-c5fe6dc4c4f5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bda4994-cdf5-47b4-aebc-7297347334e9 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Mirtazapine tablets are rapidly and completely absorbed following oral administration and have a half-life of about 20 to 40 hours.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:faba9bfd-6725-4917-ab48-24e58b397eb4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets Metabolism Mirtazapine is extensively metabolized after oral administration.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e839bb2-2f67-f224-e053-2a95a90ae5d8 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Mirtazapine tablets are rapidly and completely absorbed following oral administration and have a half-life of about 20 to 40 hours.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac976282-fb68-4db0-912a-28f075b0716c (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Mirtazapine tablets are rapidly and completely absorbed following oral administration and have a half-life of about 20 to 40 hours.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bb242b0-42ed-471a-b3c4-5ded1e292e80 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9675333e-3064-c8cb-a4b4-6c74d9a82f17 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets Metabolism Mirtazapine is extensively metabolized after oral administration.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:beaa0678-e4b9-4241-8b08-e69e2e49530f (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:356eb045-6347-49cc-818e-65b1cdff8f4e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55c5905c-6cb8-4ed4-8e69-97f733ca91b5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:98ad1917-a094-44f5-a28f-a64a8cfcd887 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of REMERON or REMERONSolTab.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3eed8213-a240-fc4b-e063-6294a90a3b05 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets Metabolism Mirtazapine is extensively metabolized after oral administration.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3b516a33-b164-4e4f-bc18-e9d1e591323a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Mirtazapine tablets are rapidly and completely absorbed following oral administration and have a half-life of about 20 to 40 hours.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a96e0d95-1a7b-4588-923a-2169b5506203 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Mirtazapine tablets are rapidly and completely absorbed following oral administration and have a half-life of about 20 to 40 hours.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ecf7826c-c583-4836-9b00-bf9e4b51a144 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20a724c6-feba-40e7-a35a-8a37de2e0136 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Mirtazapine tablets are rapidly and completely absorbed following oral administration and have a half-life of about 20 to 40 hours.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50ccc34a-4b89-4b07-b153-6c71c6924db1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a2f01ffd-fd48-499b-9126-8eb9048a5722 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Mirtazapine tablets are rapidly and completely absorbed following oral administration and have a half-life of about 20 to 40 hours.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8c03eb2b-6aed-40a1-a424-67ac1ab6085d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:35922615-7619-3852-e063-6394a90a2e55 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets Metabolism Mirtazapine is extensively metabolized after oral administration.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5127517f-b8d0-4af1-8a2f-5225719600bc (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine orally disintegrating tablets.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58e9b4c6-531f-49c4-a640-6953e70892fe (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c2b38cc5-7738-44fa-9bef-89a18a1039b2 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d1b59d87-8442-4c15-8bb9-e39b198d8677 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:82a615a0-e74a-49cb-9a57-ffbb3df604d5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac3716fd-6971-4a70-ae7b-9f5117f3d880 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8c383c1-d1b3-ceaa-e053-6294a90a6053 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6ad0e695-92ee-4900-b194-a2455473370b (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Mirtazapine tablets are rapidly and completely absorbed following oral administration and have a half-life of about 20 to 40 hours.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:500dbfbe-2a00-496d-9e44-6e59d2c68ea2 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0cda063-00c5-0921-ee39-d4de1381f91a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bd532a25-cfde-4c7d-8015-ba40609fb95c (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:51269807-2b5a-e7aa-e063-6394a90ab657 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6d2ff278-0c80-4373-b77d-b5f186c4b991 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:93c4ddcf-ca4f-4a46-a7b7-1395fb0885d2 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aa05d606-29fd-443e-802b-1d65584d6bb1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f86f1175-806f-4416-af86-b1e28def8244 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine orally disintegrating tablets.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dea8c09a-b759-1da7-e053-2a95a90a3346 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets Metabolism Mirtazapine is extensively metabolized after oral administration.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44779383-3ddb-41df-8766-da5d7bef385e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets Metabolism Mirtazapine is extensively metabolized after oral administration.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53311d08-9dfa-7bb1-e063-6394a90a6656 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:538679a1-d474-8e1c-e063-6394a90a15d7 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:10ea9d83-19c3-4f3b-a1cc-cfc48b42507f (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:222dfdde-6979-4b18-a7eb-ff1ad0a437c1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:552e2261-53db-4a27-b277-f7b62c3ea2ed (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:979eec8b-1bf4-466b-812e-85a111ce1cb5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f23631be-c7ae-46e9-b771-a70be17bc9f0 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:711aa80b-8fc6-49e6-9494-3db31d9b53a4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c47428e5-4717-4471-9231-ec8b5438205a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine orally disintegrating tablets.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a8a4490-9243-4201-944d-cea27d3d69f5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine orally disintegrating tablets.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b13d7ec-ecdc-482c-8fe2-b999bab3bbeb (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f54718d1-3ef7-4472-9e97-90e5fd30db4d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b4b9b66e-87a1-4dbb-9eaf-71221bcb2265 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aae4c58a-5cbd-45ef-b0f9-32bf28204f15 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6a5949f-5ebf-f37d-e053-2995a90adae5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e6e5cbf7-a958-4ef8-abcc-a7491edb9520 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Mirtazapine tablets are rapidly and completely absorbed following oral administration and have a half-life of about 20 to 40 hours.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:412abf0e-1f96-4d4d-bb56-a23d4699b14c (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e708e8bb-9b13-44d9-96f5-fd73a893a987 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:70439462-b632-4d21-8067-560162db3137 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c22c4325-4f1a-4d12-8039-d3b1263fa3ad (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:577c3ceb-316b-4c93-9b0c-0a4b1b4773e9 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine tablets.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e38c96d4-ea33-3f1a-e053-2a95a90a0903 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Elimination Mirtazapine has a half-life of about 20 to 40 hours following oral administration of mirtazapine.

  10. Projected row 1020

    Medicine slug
    mirtazapine
    Compared field
    tMax
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    92
    Source count
    92
    Agreement rate
    1
    Recorded readings

    1. 2 hours

      Numeric value
      2
      Unit
      hours
      Source records
      92

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 92 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7a5545a0-4dbb-48ac-b0d2-477a8dd4b87e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81d9e47e-ae81-4755-a5ee-546a038fadb4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6837b69b-2f86-42cf-b48d-b4a3c7b5413f (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:40c95daa-bbd5-48d9-97e4-c87f2c1f0fa5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f19ab40-1a30-4ac2-9bd7-c2f8199e29e1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9f0f52e8-3318-4da2-b0d9-ea3d33bfe41e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1e0006b6-9405-95a7-e063-6294a90aa277 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed491abe-9412-428b-8e24-57242862c99a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df06ea51-a962-49d0-a449-137e2220ce7e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1fb26f9b-b075-471d-8cc3-fa39246ec2e4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5539fe37-546b-40a8-e063-6394a90ace1b (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b6b31703-e77d-4d1a-b1ac-da972117e356 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58bea4d8-084f-4c30-e063-6394a90a35cb (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9135e7db-cba4-4150-a69c-fdf2a347a785 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a0689ae-5650-42d1-ac9d-56dd2b467727 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b6e946c-54b5-40e3-918f-9cc29f04cd9a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8b2a08f7-4803-42fa-a2b5-5ea51f8ef7e4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e5478a6a-a29a-9f61-e053-2995a90a11d0 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1cc1a159-11ec-4040-817b-d57fa827a773 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7727fe84-f6cc-4b31-bc00-1ecf741ad361 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50718832-88fb-dec1-e063-6294a90ae468 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb134141-6069-4b86-abac-7783bf5df60d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:89ae6a33-933f-47aa-a2de-2a71cd3f7d44 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:598e441a-aa1a-6fb3-e063-6394a90a14aa (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:67e753ad-9919-416b-9e8f-aab0fa808066 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3b7a5f44-8da6-4196-bb5d-8d2770af1b3a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ba111d1-cf92-4cd9-afcb-3bebd1bacd46 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20eafce1-50cd-0d9c-e063-6394a90ad6fe (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3699b988-6d9a-dcc1-e063-6394a90ab38d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:73b7bbd9-7dba-4559-890f-3f8dd821e215 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a80463be-f2d2-4074-9bd8-5e52b0832b3a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a4c012f0-50b6-42fb-9f06-a14632f23f2e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ded5b83b-f11a-4a6a-bf77-c5fe6dc4c4f5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bda4994-cdf5-47b4-aebc-7297347334e9 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations are reached within about 2 hours following an oral dose.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:faba9bfd-6725-4917-ab48-24e58b397eb4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e839bb2-2f67-f224-e053-2a95a90ae5d8 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations are reached within about 2 hours following an oral dose.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac976282-fb68-4db0-912a-28f075b0716c (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations are reached within about 2 hours following an oral dose.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bb242b0-42ed-471a-b3c4-5ded1e292e80 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9675333e-3064-c8cb-a4b4-6c74d9a82f17 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:beaa0678-e4b9-4241-8b08-e69e2e49530f (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:356eb045-6347-49cc-818e-65b1cdff8f4e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55c5905c-6cb8-4ed4-8e69-97f733ca91b5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:98ad1917-a094-44f5-a28f-a64a8cfcd887 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3eed8213-a240-fc4b-e063-6294a90a3b05 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3b516a33-b164-4e4f-bc18-e9d1e591323a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations are reached within about 2 hours following an oral dose.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a96e0d95-1a7b-4588-923a-2169b5506203 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations are reached within about 2 hours following an oral dose.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ecf7826c-c583-4836-9b00-bf9e4b51a144 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:20a724c6-feba-40e7-a35a-8a37de2e0136 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations are reached within about 2 hours following an oral dose.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50ccc34a-4b89-4b07-b153-6c71c6924db1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a2f01ffd-fd48-499b-9126-8eb9048a5722 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations are reached within about 2 hours following an oral dose.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8c03eb2b-6aed-40a1-a424-67ac1ab6085d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:35922615-7619-3852-e063-6394a90a2e55 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5127517f-b8d0-4af1-8a2f-5225719600bc (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58e9b4c6-531f-49c4-a640-6953e70892fe (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c2b38cc5-7738-44fa-9bef-89a18a1039b2 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d1b59d87-8442-4c15-8bb9-e39b198d8677 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:82a615a0-e74a-49cb-9a57-ffbb3df604d5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac3716fd-6971-4a70-ae7b-9f5117f3d880 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8c383c1-d1b3-ceaa-e053-6294a90a6053 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6ad0e695-92ee-4900-b194-a2455473370b (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations are reached within about 2 hours following an oral dose.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:500dbfbe-2a00-496d-9e44-6e59d2c68ea2 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0cda063-00c5-0921-ee39-d4de1381f91a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bd532a25-cfde-4c7d-8015-ba40609fb95c (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:51269807-2b5a-e7aa-e063-6394a90ab657 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6d2ff278-0c80-4373-b77d-b5f186c4b991 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:93c4ddcf-ca4f-4a46-a7b7-1395fb0885d2 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aa05d606-29fd-443e-802b-1d65584d6bb1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f86f1175-806f-4416-af86-b1e28def8244 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dea8c09a-b759-1da7-e053-2a95a90a3346 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44779383-3ddb-41df-8766-da5d7bef385e (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53311d08-9dfa-7bb1-e063-6394a90a6656 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:538679a1-d474-8e1c-e063-6394a90a15d7 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:10ea9d83-19c3-4f3b-a1cc-cfc48b42507f (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:222dfdde-6979-4b18-a7eb-ff1ad0a437c1 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:552e2261-53db-4a27-b277-f7b62c3ea2ed (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:979eec8b-1bf4-466b-812e-85a111ce1cb5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f23631be-c7ae-46e9-b771-a70be17bc9f0 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:711aa80b-8fc6-49e6-9494-3db31d9b53a4 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c47428e5-4717-4471-9231-ec8b5438205a (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a8a4490-9243-4201-944d-cea27d3d69f5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b13d7ec-ecdc-482c-8fe2-b999bab3bbeb (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f54718d1-3ef7-4472-9e97-90e5fd30db4d (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b4b9b66e-87a1-4dbb-9eaf-71221bcb2265 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aae4c58a-5cbd-45ef-b0f9-32bf28204f15 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a6a5949f-5ebf-f37d-e053-2995a90adae5 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e6e5cbf7-a958-4ef8-abcc-a7491edb9520 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations are reached within about 2 hours following an oral dose.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:412abf0e-1f96-4d4d-bb56-a23d4699b14c (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e708e8bb-9b13-44d9-96f5-fd73a893a987 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:70439462-b632-4d21-8067-560162db3137 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c22c4325-4f1a-4d12-8039-d3b1263fa3ad (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:577c3ceb-316b-4c93-9b0c-0a4b1b4773e9 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e38c96d4-ea33-3f1a-e053-2a95a90a0903 (opens source in a new tab)

        Mirtazapine label

        Version not recorded · Effective date not recorded

        Peak plasma concentrations of mirtazapine are reached within about 2 hours post dose.

Access

Query or download the projection

View this filtered page as JSONDownload up to 200 filtered CSV rows
GET /api/datasets/source-consensus?limit=10&offset=1010

Allowed query parameters

q
Case-insensitive text search over the public fields named for this dataset.
state
Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
field
Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
limit / offset
Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.

Reuse and corrections

Keep the boundary attached

CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.

Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.

Read the correction policy